Artelo Biosciences P/E Ratio

Artelo Biosciences (ARTL) currently reports a P/E ratio of -0.08. That is below the Consumer Staples sector average of 23.35. Use the charts on this page to explore Artelo Biosciences's P/E ratio history and peer comparisons.

Artelo Biosciences's P/E ratio of -0.08 is lower than the Consumer Staples sector average of 23.35. That is roughly 100.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Artelo Biosciences's market price to a fundamental measure such as earnings, sales, or book value. At -0.08, ARTL can look expensive or cheap only in context — versus its own history, growth rate, and Consumer Staples peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -0.08, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Staples average is 23.35. From there, open related valuation or income-statement pages for Artelo Biosciences, and consider following ARTL for alerts when major investors trade the stock.

Artelo Biosciences is classified in the Consumer Staples sector. On P/E ratio, it currently shows -0.08 versus a sector average near 23.35. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing ARTL with unrelated industries.